Tycel Jovelle Phillips, MD, University of Michigan
Advertisement
Articles by Tycel Jovelle Phillips, MD, University of Michigan
Advertisement
Latest Updated Articles
Novel Agents and Ongoing Trials in R/R Follicular LymphomaPublished: December 6th 2021 | Updated:
Emerging Agents for R/R MZLPublished: December 21st 2021 | Updated:
Rapid Readouts: Results from the Phase 3 CHRONOS-3 Trial for Relapsed iNHLPublished: May 7th 2021 | Updated:
CHRONOS-1 and CHRONOS-3 Trials in R/R FL and Clinical ImplicationsPublished: November 29th 2021 | Updated:
Dr. Phillips on the Future of CAR T-Cell Therapy in MCLPublished: August 2nd 2021 | Updated:
- Role of Tazemetostat and Selecting Appropriate Therapies in R/R FL
Published: November 29th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
5